RIDOCAINE-CONTAINING APPLICATION AGENT FOR EXTERNAL USE
PURPOSE:To obtain an application agent for external use, containing ridocaine as a pharmacodynamically effective ingredient dispersed or dissolved in a water- soluble polymeric substance and capable of stably and percutaneously absorbing the aforementioned pharmacodynamically effective ingredient fo...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | IWAMOTO KIYOMI KONISHI RYOSHI SEKI MICHIKO AKAZAWA MITSUJI ONO MASAHIRO |
description | PURPOSE:To obtain an application agent for external use, containing ridocaine as a pharmacodynamically effective ingredient dispersed or dissolved in a water- soluble polymeric substance and capable of stably and percutaneously absorbing the aforementioned pharmacodynamically effective ingredient for a long period. CONSTITUTION:An application agent for external use is obtained by blending 1-10wt.% ridocaine or its salt (e.g. ridocaine hydrochloride) in a tacky gel base containing 5-25wt.% water-soluble high molecular substance (e.g. gelatin, alginic acid, CMC or PVA), 20-50wt.% water and 10-60wt.% water-holding agent (e.g. glycolic acids or saccharides) as essential ingredients and providing the resultant chemical-holding layer on a support. The aforementioned base can be blended with 0.01-10wt.% super highly water absorbing polymeric substance (e.g. starch- acrylonitrile graft substance) and further, as necessary, an absorption assistant and a surfactant so as to more improve the water-holding properties. Sustained release of the pharmacodynamically effective ingredient for a long period can be carried out by using the above-mentioned application agent and stable pharmacodynamic effects can always be expected. The aforementioned agent is effective in treating zoster neuralgia and neuralgia after the zoster. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH04305523A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH04305523A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH04305523A3</originalsourceid><addsrcrecordid>eNrjZDAP8nTxd3b09HPVdfb3CwEyPP3cFRwDAnw8nR1DPP39FBzdXf1CFNz8gxRcI0Jcg_wcfRRCg115GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8V4CHgYmxgampkbGjMTFqAEl5KGs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RIDOCAINE-CONTAINING APPLICATION AGENT FOR EXTERNAL USE</title><source>esp@cenet</source><creator>IWAMOTO KIYOMI ; KONISHI RYOSHI ; SEKI MICHIKO ; AKAZAWA MITSUJI ; ONO MASAHIRO</creator><creatorcontrib>IWAMOTO KIYOMI ; KONISHI RYOSHI ; SEKI MICHIKO ; AKAZAWA MITSUJI ; ONO MASAHIRO</creatorcontrib><description>PURPOSE:To obtain an application agent for external use, containing ridocaine as a pharmacodynamically effective ingredient dispersed or dissolved in a water- soluble polymeric substance and capable of stably and percutaneously absorbing the aforementioned pharmacodynamically effective ingredient for a long period. CONSTITUTION:An application agent for external use is obtained by blending 1-10wt.% ridocaine or its salt (e.g. ridocaine hydrochloride) in a tacky gel base containing 5-25wt.% water-soluble high molecular substance (e.g. gelatin, alginic acid, CMC or PVA), 20-50wt.% water and 10-60wt.% water-holding agent (e.g. glycolic acids or saccharides) as essential ingredients and providing the resultant chemical-holding layer on a support. The aforementioned base can be blended with 0.01-10wt.% super highly water absorbing polymeric substance (e.g. starch- acrylonitrile graft substance) and further, as necessary, an absorption assistant and a surfactant so as to more improve the water-holding properties. Sustained release of the pharmacodynamically effective ingredient for a long period can be carried out by using the above-mentioned application agent and stable pharmacodynamic effects can always be expected. The aforementioned agent is effective in treating zoster neuralgia and neuralgia after the zoster.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1992</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19921028&DB=EPODOC&CC=JP&NR=H04305523A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19921028&DB=EPODOC&CC=JP&NR=H04305523A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IWAMOTO KIYOMI</creatorcontrib><creatorcontrib>KONISHI RYOSHI</creatorcontrib><creatorcontrib>SEKI MICHIKO</creatorcontrib><creatorcontrib>AKAZAWA MITSUJI</creatorcontrib><creatorcontrib>ONO MASAHIRO</creatorcontrib><title>RIDOCAINE-CONTAINING APPLICATION AGENT FOR EXTERNAL USE</title><description>PURPOSE:To obtain an application agent for external use, containing ridocaine as a pharmacodynamically effective ingredient dispersed or dissolved in a water- soluble polymeric substance and capable of stably and percutaneously absorbing the aforementioned pharmacodynamically effective ingredient for a long period. CONSTITUTION:An application agent for external use is obtained by blending 1-10wt.% ridocaine or its salt (e.g. ridocaine hydrochloride) in a tacky gel base containing 5-25wt.% water-soluble high molecular substance (e.g. gelatin, alginic acid, CMC or PVA), 20-50wt.% water and 10-60wt.% water-holding agent (e.g. glycolic acids or saccharides) as essential ingredients and providing the resultant chemical-holding layer on a support. The aforementioned base can be blended with 0.01-10wt.% super highly water absorbing polymeric substance (e.g. starch- acrylonitrile graft substance) and further, as necessary, an absorption assistant and a surfactant so as to more improve the water-holding properties. Sustained release of the pharmacodynamically effective ingredient for a long period can be carried out by using the above-mentioned application agent and stable pharmacodynamic effects can always be expected. The aforementioned agent is effective in treating zoster neuralgia and neuralgia after the zoster.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1992</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAP8nTxd3b09HPVdfb3CwEyPP3cFRwDAnw8nR1DPP39FBzdXf1CFNz8gxRcI0Jcg_wcfRRCg115GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8V4CHgYmxgampkbGjMTFqAEl5KGs</recordid><startdate>19921028</startdate><enddate>19921028</enddate><creator>IWAMOTO KIYOMI</creator><creator>KONISHI RYOSHI</creator><creator>SEKI MICHIKO</creator><creator>AKAZAWA MITSUJI</creator><creator>ONO MASAHIRO</creator><scope>EVB</scope></search><sort><creationdate>19921028</creationdate><title>RIDOCAINE-CONTAINING APPLICATION AGENT FOR EXTERNAL USE</title><author>IWAMOTO KIYOMI ; KONISHI RYOSHI ; SEKI MICHIKO ; AKAZAWA MITSUJI ; ONO MASAHIRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH04305523A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1992</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>IWAMOTO KIYOMI</creatorcontrib><creatorcontrib>KONISHI RYOSHI</creatorcontrib><creatorcontrib>SEKI MICHIKO</creatorcontrib><creatorcontrib>AKAZAWA MITSUJI</creatorcontrib><creatorcontrib>ONO MASAHIRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IWAMOTO KIYOMI</au><au>KONISHI RYOSHI</au><au>SEKI MICHIKO</au><au>AKAZAWA MITSUJI</au><au>ONO MASAHIRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RIDOCAINE-CONTAINING APPLICATION AGENT FOR EXTERNAL USE</title><date>1992-10-28</date><risdate>1992</risdate><abstract>PURPOSE:To obtain an application agent for external use, containing ridocaine as a pharmacodynamically effective ingredient dispersed or dissolved in a water- soluble polymeric substance and capable of stably and percutaneously absorbing the aforementioned pharmacodynamically effective ingredient for a long period. CONSTITUTION:An application agent for external use is obtained by blending 1-10wt.% ridocaine or its salt (e.g. ridocaine hydrochloride) in a tacky gel base containing 5-25wt.% water-soluble high molecular substance (e.g. gelatin, alginic acid, CMC or PVA), 20-50wt.% water and 10-60wt.% water-holding agent (e.g. glycolic acids or saccharides) as essential ingredients and providing the resultant chemical-holding layer on a support. The aforementioned base can be blended with 0.01-10wt.% super highly water absorbing polymeric substance (e.g. starch- acrylonitrile graft substance) and further, as necessary, an absorption assistant and a surfactant so as to more improve the water-holding properties. Sustained release of the pharmacodynamically effective ingredient for a long period can be carried out by using the above-mentioned application agent and stable pharmacodynamic effects can always be expected. The aforementioned agent is effective in treating zoster neuralgia and neuralgia after the zoster.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_JPH04305523A |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | RIDOCAINE-CONTAINING APPLICATION AGENT FOR EXTERNAL USE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T17%3A24%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IWAMOTO%20KIYOMI&rft.date=1992-10-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH04305523A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |